Bryophytes produce a large variety of secondary plant products that are not known from higher plants including various sesqui‐, di and triterpenes, bibenzyl‐, bisbibenzyl‐, and phenanthren derivatives. Field collection of bryophytes is difficult and often leads to only minor amounts of these tiny plants.
An alternative is
in vitro
culture. It has been shown in many examples that these cultures produce qualitatively and quantitatively the same secondary products. The cultures may also serve for biotransformation and biosynthetic studies.
Recently,
in vitro
cultures of the moss
Physcomitrella patens
were genetically transformed to produce therapeutically active proteins such as the human vascular endothelial growth factor, erythropoietin, and immunoglobulin.